Download FREE Sample
Table of Contents
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Market Forecasting
- Executive Summary
- Market Overview
- Market Dynamics
- Drivers
- Restraints
- Key Market Trends
- Market Dynamics
-
- Industry Speaks
- Key Revenue Pockets
- Global Non-Invasive Prenatal Testing Market - Size & Forecast (2021-2028), By Product Type
- Consumables
- Kits & Reagents
- Instruments
- Others
- Global Non-Invasive Prenatal Testing Market - Size & Forecast (2021-2028), By Application Type
- Trisomy
- Microdeletion Syndrome
- Others
- Global Non-Invasive Prenatal Testing Market - Size & Forecast (2021-2028), By End User
- Hospitals
- Clinics
- Diagnostic Laboratories
- Others
- Global Non-Invasive Prenatal Testing - Size & Forecast (2021-2028), By Region
- North America (U.S. & Canada)
- Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
- Asia Pacific (China, India, Japan, Rest of Asia Pacific)
- Rest of the World (Latin America, Middle East & Africa)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Competitive Positioning of Key Players (2022)
- Offerings Assessment, By Player
- Key Strategies Assessment, By Player (2021-2023)
- New Product & Service Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Key Companies Scanned (Indicative List)
- Agilent Technologies, Inc.
- PerkinElmer, Inc.
- Illumina, Inc.
- Eurofins LifeCodexx AG
- Natera, Inc.
- Igenomix SL
- Hoffman-La Roche Ltd.
- BGI Genomics
- Quest Diagnostics
- Berry Genomics
- Yourgene Health
- Other Prominent Players
